EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
ramusmedical
Editorial Archive

Quality-of-life Improvements for Heart Health in Scarce Treatment Settings

When medical circumstances are severe and treatment options are limited in number or effectiveness, being able to help patients improve their quality of life (QOL) t...
19 April 2024 Editorial Archive | Volume 16 Issue 1 circumstances | effectiveness
Continue Reading →
Editorial Archive

Generative AI is Revolutionising Life Sciences, And We’re Just Scratching the Surface

On average, it takes about seven years to develop a new drug and bring it to market. For ambitious life science businesses, generative AI’s ability to generate insig...
19 April 2024 Editorial Archive | Volume 16 Issue 1 AI | clinical
Continue Reading →
Europe

RWS Life Sciences Welcomes New VP of Quality

Clarice Streets joins RWS as VP of Quality for Life Sciences Division RWS Life Sciences welcomes Clarice Streets, ASQ, CMQ, OE, as Vice President, Global Quality and ...
18 July 2018 Europe life | New
Continue Reading →
Europe

Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease

ANAVEX®2-73 Being Studied as Potential First Precision Medicine Biomarker-guided, Targeted Therapeutic in Alzheimer’s Disease Primary and Secondary Endpoints mea...
4 July 2018 Europe | North America anavex | approval
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte